Opportunistic Infections Citation List: June 5 - June 18, 2015
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
1. Synthesis and in Vitro Antimycobacterial Activity of B-ring Modified Diaryl ether InhA Inhibitors. am Ende, C.W., S.E. Knudson, N. Liu, J. Childs, T.J. Sullivan, M. Boyne, H. Xu, Y. Gegina, D.L. Knudson, F. Johnson, C.A. Peloquin, R.A. Slayden, and P.J. Tonge. Bioorganic & Medicinal Chemistry Letters, 2008. 18(10): p. 3029-3033. PMID[18457948].
[PubMed]. OI_0605-061815.
2. First Crystal Structures of Mycobacterium Tuberculosis 6-Oxopurine phosphoribosyltransferase: Complexes with GMP and Pyrophosphate and with Acyclic Nucleoside Phosphonates Whose Prodrugs Have Antituberculosis Activity. Eng, W.S., D. Hockova, P. Spacek, Z. Janeba, N.P. West, K. Woods, L.M. Naesens, D.T. Keough, and L.W. Guddat. Journal of Medicinal Chemistry, 2015. 58(11): p. 4822-4838. PMID[25915781].
[PubMed]. OI_0605-061815.
3. Triclosan Derivatives: Towards Potent Inhibitors of Drug-sensitive and Drug-resistant Mycobacterium tuberculosis. Freundlich, J.S., F. Wang, C. Vilcheze, G. Gulten, R. Langley, G.A. Schiehser, D.P. Jacobus, W.R.J. Jr., and J.C. Sacchettini. ChemMedChem, 2009. 4(2)(1860-7187): p. 241-248. PMID[19130456].
[PubMed]. OI_0605-061815.
4. Synthesis, Antimycobacterial Evaluation and Pharmacophore Modeling of Analogues of the Natural Product Formononetin. Mutai, P., E. Pavadai, I. Wiid, A. Ngwane, B. Baker, and K. Chibale. Bioorganic & Medicinal Chemistry Letters, 2015. 25(12): p. 2510-2513. PMID[25977095].
[PubMed]. OI_0605-061815.
5. Structure-based Design of Diverse Inhibitors of Mycobacterium tuberculosis N-Acetylglucosamine-1-phosphate uridyltransferase: Combined Molecular Docking, Dynamic Simulation, and Biological Activity. Soni, V., P. Suryadevara, D. Sriram, S. Kumar, V.K. Nandicoori, and P. Yogeeswari. Journal of Molecular Modeling, 2015. 21(7): p. 2704. PMID[26078037].
[PubMed]. OI_0605-061815.
6. High Affinity InhA Inhibitors with Activity against Drug-resistant Strains of Mycobacterium Tuberculosis. Sullivan, T.J., J.J. Truglio, M.E. Boyne, P. Novichenok, X. Zhang, C.F. Stratton, H.J. Li, T. Kaur, A. Amin, F. Johnson, R.A. Slayden, C. Kisker, and P.J. Tonge. ACS Chemical Biology, 2006. 1(1): p. 43-53. PMID[17163639].
[PubMed]. OI_0605-061815.
7. Synthesis, and Structure-activity Relationship for C(4) and/or C(5) Thienyl Substituted Pyrimidines, as a New Family of Antimycobacterial Compounds. Verbitskiy, E.V., E.M. Cheprakova, P.A. Slepukhin, M.A. Kravchenko, S.N. Skornyakov, G.L. Rusinov, O.N. Chupakhin, and V.N. Charushin. European Journal of Medicinal Chemistry, 2015. 97: p. 225-234. PMID[25982331].
[PubMed]. OI_0605-061815.
Citations from the ISI Web of Knowledge Listings for O.I.
8. Diterpenes Synthesized from the Natural Serrulatane Leubethanol and their in Vitro Activities against Mycobacterium tuberculosis. Escarcena, R., J. Perez-Meseguer, E. del Olmo, B. Alanis-Garza, E. Garza-Gonzalez, R. Salazar-Aranda, and N.W. de Torres. Molecules, 2015. 20(4): p. 7245-7262. ISI[000354480700119].
[WOS]. OI_0605-061815.